Rheumatism and chronic fatigue, the two facets of post-chikungunya disease: the TELECHIK cohort study on Reunion island.
A Duvignaud, A Fianu, A Bertolotti, J Jaubert, A Michault, P Poubeau, A Fred, M Méchain, B-A Gaüzère, F Favier, D Malvy, P Gérardin
Author Information
A Duvignaud: Department of Tropical Medicine and Clinical International Health, Division of Infectious Diseases and Tropical Medicine, CHU Bordeaux, Bordeaux, France.
A Fianu: INSERM CIC 1410, CHU Réunion, Saint Pierre, Reunion.
A Bertolotti: Department of Infectious Diseases, CHU Réunion, Saint Pierre, Reunion.
J Jaubert: Bacteriology, Virology and Parasitology lab, CHU Réunion, Saint Pierre, Reunion.
A Michault: Bacteriology, Virology and Parasitology lab, CHU Réunion, Saint Pierre, Reunion.
P Poubeau: Department of Infectious Diseases, CHU Réunion, Saint Pierre, Reunion.
A Fred: INSERM CIC 1410, CHU Réunion, Saint Pierre, Reunion.
M Méchain: Department of Tropical Medicine and Clinical International Health, Division of Infectious Diseases and Tropical Medicine, CHU Bordeaux, Bordeaux, France.
B-A Gaüzère: Polyvalent Intensive Care Unit, CHU Réunion, Saint Denis, Reunion.
F Favier: INSERM CIC 1410, CHU Réunion, Saint Pierre, Reunion.
D Malvy: Department of Tropical Medicine and Clinical International Health, Division of Infectious Diseases and Tropical Medicine, CHU Bordeaux, Bordeaux, France.
P Gérardin: INSERM CIC 1410, CHU Réunion, Saint Pierre, Reunion. ORCID
Prolonged fatigue is increasingly reported among chikungunya virus (CHIKV)-infected populations. We investigated the relationships between CHIKV exposure, long-lasting rheumatic musculoskeletal pain (LRMSP) and chronic fatigue. 1094 participants (512 CHIKV seropositive and 582 seronegative) of the TELECHIK population-based cohort were analysed considering the duration of the manifestations throughout an average 2-year follow-up. Weighted prevalence rates and prevalence ratios for LRMSP, idiopathic chronic fatigue (ICF), and chronic fatigue syndrome (CFS)-like illness, both latter syndromes adapted from Centers for Disease Control (CDC)-1994/Fukuda criteria, were compared. Population attributable fractions (PAF) were estimated to assess the contribution of CHIKV infection to each of the three phenotypes. Among 362 adult subjects who had reported either rheumatic pain or fatigue at the onset of the infection, weighted prevalence rates of LRMSP, ICF and CFS-like illness were respectively of 32.9%, 38.7% and 23.9%, and of 8.7%, 8.5% and 7.4% among initially asymptomatic peers (P < 0.01, respectively). Each of the three outcomes was highly attributable to chikungunya (PAF of 43.2%, 36.2% and 41.0%, respectively). In the sub-cohort of CHIKV-infected subjects, LRMSP, ICF and CFS-like illness, which overlapped in 70%, accounted for 53% of the chronic manifestations. In addition to rheumatic disease, chronic fatigue could be considered in caring for patients with chronic chikungunya disease.
